-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… ) and non-small cell lung cancer (NSCLC). In patients with … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no … with trastuzumab and CAPOX (capecitabine plus oxaliplatin) or FP …
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02 Jul 2025 22:28 GMT
… the FDA in combination with capecitabine for the treatment of adult … the treatment of small cell lung cancer and breast cancer. In February … with extensive-stage small cell lung cancer. In November 2024, Puma initiated …
-
Study of Combined TIGIT/PD-1 Blockade Signals Potential Shift in Gastric Cancer Management
30 Jun 2025 21:30 GMT
… , leucovorin, and oxaliplatin) or CAPOX (capecitabine and oxaliplatin) vs nivolumab (Opdivo … melanoma, gynecological cancer, and lung cancer. The lung cancer trial showed a borderline benefit …
-
Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets
28 Apr 2025 17:19 GMT
… pharmacologic interventions: eribulin, capecitabine and paclitaxel (Figure … Resistance to Eribulin, Capecitabine and Paclitaxel results … progression on eribulin, capecitabine and paclitaxel, respectively. … with non-small cell lung cancer. Clin Transl Oncol …
-
Cardio-Oncology Considerations for Breast Cancer: Risk Stratification, Monitoring, and Treatment
26 Jun 2025 23:48 GMT
… inhibitors (ICIs), and PARP inhibitors. Capecitabine is an oral prodrug of … mortality from heart disease and lung cancer after radiotherapy for early breast …
-
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
03 Jun 2024 18:48 GMT
… advanced osimertinib-resistant EGFR-mutated lung cancer,” was presented by Turja Chakrabarti … the FDA in combination with capecitabine for the treatment of adult … with extensive-stage small cell lung cancer.
Further information about Puma Biotechnology …
-
Bevacizumab by F. Hoffmann-La Roche for Small-Cell Lung Cancer: Likelihood of Approval
17 May 2024 03:08 GMT
… Avastin in combination with xeloda or paclitaxel is indicated … squamous non-small cell lung cancer (with carboplatin and … carcinoma, non-small cell lung cancer, metastatic colorectal cancer, … adjuvant non small cell lung cancer (NSCLC), metastatic liver …
-
Impact of Intravenous Fish Oil Lipid Emulsion on Short-Term Postoperative Outcomes in Rectal Cancer Patients Following Neoadjuvant Therapy: A Propensity Score-Matched Study
23 Jun 2025 12:52 GMT
… administering FOLFOX (fluorouracil + oxaliplatin), XELOX (capecitabine + oxaliplatin), or FOLFOXIRI (fluorouracil + … 2 Gy), with concurrent oral capecitabine (825 mg/m², … fatty acids in patients with lung cancer undergoing radiotherapy and chemotherapy: …
-
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
04 Mar 2024 10:29 GMT
… nonsquamous non-small cell lung cancer (NSCLC) who … -agent chemotherapy (eribulin, capecitabine, vinorelbine or gemcitabine) … Small Cell Lung Cancer
Nearly 500,000 lung cancer cases were … References:
1 Cancer.net. Lung Cancer – Non-Small Cell: Statistics …
-
Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
13 Feb 2024 13:43 GMT
… for alisertib in small cell lung cancer.
“Treatment options for … of alisertib in small cell lung cancer and, more specifically, … FDA in combination with capecitabine for the treatment of … the treatment of small cell lung cancer and breast cancer.
Further …
About
© 1995-2025